| scholarly article | Q13442814 |
| P2093 | author name string | Krajewski S | |
| Reed JC | |||
| Cheng W | |||
| Anversa P | |||
| Kajstura J | |||
| Clark WA | |||
| Sonnenblick EH | |||
| Olivetti G | |||
| Reiss K | |||
| P433 | issue | 1 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 86-107 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats | |
| P478 | volume | 74 |
| Q46800364 | (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats |
| Q44687021 | 18F-labelled annexin V: a PET tracer for apoptosis imaging |
| Q33962701 | 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways |
| Q27667526 | A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes |
| Q33836284 | A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury |
| Q33293545 | A novel dual staining method for identification of apoptotic cells reveals a modest apoptotic response in infarcted mouse myocardium |
| Q45143633 | AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat. |
| Q38637311 | Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases |
| Q34997854 | Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy |
| Q40746819 | Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress |
| Q24606408 | Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice |
| Q53469228 | Administration of zinc complex of acetylsalicylic acid after the onset of myocardial injury protects the heart by upregulation of antioxidant enzymes. |
| Q47677058 | Age and ischemia differentially impact mitochondrial ultrastructure and function in a novel model of age-associated estrogen deficiency in the female rat heart |
| Q39870130 | Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. |
| Q41811962 | Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia |
| Q35949609 | Angiogenic signal during cardiac repair |
| Q35043224 | Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells |
| Q42285436 | Antiapoptotic mechanisms of benidipine in the ischemic/reperfused heart |
| Q37397983 | Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking. |
| Q42078470 | Apoptosis after reperfused myocardial infarction: Role of angiotensin II. |
| Q36080910 | Apoptosis and oncosis in acute coronary syndromes: assessment and implications |
| Q81576039 | Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction |
| Q41343462 | Apoptosis in cardiovascular disease |
| Q30846548 | Apoptosis in dilated cardiomyopathy |
| Q22242031 | Apoptosis in myocardial ischaemia and infarction |
| Q34629107 | Apoptosis in the cardiovascular system |
| Q41280990 | Apoptosis in the heart: when and why? |
| Q41307431 | Apoptosis induced by parasitic diseases |
| Q28511114 | Apoptosis repressor with a CARD domain (ARC) restrains Bax-mediated pathogenesis in dystrophic skeletal muscle |
| Q92617006 | Atractylodesin III maintains mitochondrial function and inhibits caspase-3 activity to reverse apoptosis of cardiomyocytes in AMI rats |
| Q95821296 | Atrial fibrillation and atrial fibrosis |
| Q36278847 | BNIP3 promotes calcium and calpain-dependent cell death |
| Q36234120 | Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion |
| Q64977982 | Blockade of RBP-J-Mediated Notch Signaling Pathway Exacerbates Cardiac Remodeling after Infarction by Increasing Apoptosis in Mice. |
| Q37650499 | Both castration and goserelin acetate ameliorate myocardial ischemia reperfusion injury and apoptosis in male rats |
| Q36933115 | CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice |
| Q37986552 | Cardiac cell therapy: boosting mesenchymal stem cells effects |
| Q37221281 | Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase |
| Q35075553 | Cardiac remodeling and physical training post myocardial infarction |
| Q37836529 | Cardiomyocyte death: insights from molecular and microstructural magnetic resonance imaging |
| Q35657122 | Cardiomyocyte death: mechanisms and translational implications |
| Q42178032 | Cardioprotective effects of alpha-lipoic Acid on myocardial reperfusion injury: suppression of reactive oxygen species generation and activation of mitogen-activated protein kinase |
| Q33785805 | Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent |
| Q37567882 | Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo |
| Q42571029 | Cell death, dysglycemia and myocardial infarction |
| Q41765213 | Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery |
| Q35764091 | Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion |
| Q36635808 | Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury |
| Q41832646 | Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults |
| Q46211547 | Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury |
| Q48116601 | Concepts of tissue injury and cell death in inflammation: a historical perspective |
| Q40218554 | Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion |
| Q33815808 | Cyclophilins and their possible role in the stress response |
| Q37575962 | Cyclosporin A in left ventricular remodeling after myocardial infarction |
| Q33863961 | Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance |
| Q35772306 | Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarction |
| Q57035159 | Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction |
| Q35695495 | Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol |
| Q36437704 | Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats |
| Q28345320 | Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process |
| Q92572385 | E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis |
| Q33862492 | Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction |
| Q37222474 | Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction: a role for toll-like receptor 4. |
| Q37956569 | Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review |
| Q24813684 | Effect of the degree of ischaemic injury and reoxygenation time on the type of myocardial cell death in man: role of caspases |
| Q34088930 | Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart |
| Q40484694 | Effects of Shenqi Fuzheng injection on Fas/FasL protein expression levels in the cardiomyocytes of a mouse model of viral myocarditis |
| Q36977754 | Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction |
| Q37379734 | Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes |
| Q30498584 | Enhancing or eliminating signals for cell survival to treat disease. |
| Q26853220 | Epigenetic mechanisms underlying cardiac degeneration and regeneration |
| Q27334040 | Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy. |
| Q36389505 | Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis |
| Q35377410 | Exercise induced myocardial ischaemia does not cause increase in C-reactive protein concentration |
| Q50461855 | Exogenous midkine administration prevents cardiac remodeling in pacing-induced congestive heart failure of rabbits. |
| Q33656526 | Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells |
| Q37518459 | Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. |
| Q47377679 | Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function |
| Q54472406 | Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues. |
| Q37777353 | Granulocyte colony-stimulating factor for ischemic heart failure: should we use it? |
| Q42041495 | H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes. |
| Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
| Q49721098 | Hyperpolarized [1,4-13C2]Fumarate Enables Magnetic Resonance-Based Imaging of Myocardial Necrosis |
| Q28577311 | Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. |
| Q33853515 | Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. |
| Q42209981 | IL-17A promotes ventricular remodeling after myocardial infarction |
| Q39019273 | Immunohistochemical detection of early myocardial infarction: a systematic review |
| Q73304076 | Immunohistochemical study on tissue transglutaminase and copper-zinc superoxide dismutase in human myocardium: its relevance to apoptosis detected by the nick end labelling method |
| Q35782103 | In situ apoptosis assay for the detection of early acute myocardial infarction |
| Q34717828 | In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits |
| Q82387591 | Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction |
| Q91940252 | Influence of the plasminogen activator system on necrosis in acute myocardial infarction: analysis of urokinase- and urokinase receptor-knockout mouse models |
| Q42236378 | Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective |
| Q35377119 | Interleukin 18 in acute myocardial infarction |
| Q37556429 | Interleukin-37 and Dendritic Cells Treated With Interleukin-37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction |
| Q34497101 | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury |
| Q36182799 | Involvement of AQP 1 in the cardio-protective effect of remifentanil post-conditioning in ischemia/reperfusion rats |
| Q28576800 | Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury |
| Q36152106 | Involvement of UTP in protection of cardiomyocytes from hypoxic stress. |
| Q77418496 | Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion |
| Q34654773 | Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice |
| Q47395547 | Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats |
| Q37308645 | Matrix metalloproteinases: drug targets for myocardial infarction |
| Q50492371 | Mechanism of cell death of rat cardiac fibroblasts induced by serum depletion |
| Q35697472 | Mechanisms of apoptosis in the heart |
| Q37330076 | Mechanisms of cell death in heart disease |
| Q34234464 | Mesenchymal stromal cells: current understanding and clinical status |
| Q33713970 | Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. |
| Q28280031 | Micronized purified flavonoid fraction in pretreating CABG patients |
| Q38019459 | Mitochondria in heart failure: the emerging role of mitochondrial dynamics |
| Q35492308 | Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion |
| Q90187491 | Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury |
| Q37054218 | Mitochondrial centrality in heart failure |
| Q33596970 | Molecular Imaging of Myocardial Injury: A Magnetofluorescent Approach |
| Q36019004 | Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium |
| Q37428313 | Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia |
| Q24814079 | Molecular and cellular mechanisms of cardiotoxicity |
| Q48221861 | Molecular imaging of cardiac remodelling after myocardial infarction |
| Q49835908 | Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers. |
| Q36430856 | Morphological aspects of apoptosis in heart diseases |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q77083012 | Myocardial DNA strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy |
| Q35213048 | Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. |
| Q33712155 | Myocardial preconditioning: basic concepts and potential mechanisms. |
| Q39790463 | Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53 |
| Q42194690 | Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium |
| Q37959805 | New roles for mitochondria in cell death in the reperfused myocardium |
| Q41375785 | Nipping at cardiac remodeling. |
| Q37465955 | Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarction |
| Q35776857 | Noninvasive imaging of myocyte apoptosis following application of a stem cell-engineered delivery platform to acutely infarcted myocardium |
| Q53442597 | Nucleostemin exerts anti-apoptotic function via p53 signaling pathway in cardiomyocytes. |
| Q36800968 | Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction |
| Q37090521 | Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice |
| Q42092061 | Overexpression of IAP-2 attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice |
| Q92469263 | Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway |
| Q37373506 | Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy |
| Q36952671 | Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo |
| Q43233333 | Overexpression of the NHE1 isoform of the Na(+)/H (+) exchanger causes elevated apoptosis in isolated cardiomyocytes after hypoxia/reoxygenation challenge |
| Q50917391 | Persistence of apoptosis and inflammatory responses in the heart and bone marrow of mice following whole-body exposure to ²⁸Silicon (²⁸Si) ions. |
| Q37364441 | Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1. |
| Q37051197 | Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. |
| Q53600996 | Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. |
| Q33346851 | Protective effect of ultra low molecular weight heparin on glutamate-induced apoptosis in cortical cells |
| Q33678033 | Protein Kinases as Drug Development Targets for Heart Disease Therapy |
| Q28084341 | Quality control systems in cardiac aging |
| Q33559727 | RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. |
| Q43192890 | Reduction of cardiac cell death after helium postconditioning in rats: transcriptional analysis of cell death and survival pathways |
| Q46405553 | Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition |
| Q36281111 | Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets |
| Q78130140 | Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase |
| Q36980730 | Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase |
| Q34531697 | Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism |
| Q64085233 | Retinol palmitate protects against myocardial ischemia/reperfusion injury via reducing oxidative stress and inhibiting apoptosis |
| Q46843785 | Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice. |
| Q52583529 | Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. |
| Q36623740 | TNF-alpha is involved in activating DNA fragmentation in skeletal muscle |
| Q35113470 | Targeting extracellular DNA to deliver IGF-1 to the injured heart |
| Q42937750 | Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q37039373 | The E-domain region of mechano-growth factor inhibits cellular apoptosis and preserves cardiac function during myocardial infarction |
| Q41110486 | The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas. |
| Q37117825 | The discovery of a novel inhibitor of apoptotic protease activating factor-1 (Apaf-1) for ischemic heart: synthesis, activity and target identification |
| Q37240181 | The effect of dietary red palm oil on the functional recovery of the ischaemic/reperfused isolated rat heart: the involvement of the PI3-kinase signaling pathway |
| Q35987663 | The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis |
| Q91582380 | The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5 |
| Q37139791 | The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion |
| Q53287018 | The protective effect of peony extract on acute myocardial infarction in rats |
| Q37194572 | The rationale for cardiomyocyte resuscitation in myocardial salvage |
| Q34954474 | The role and modulation of autophagy in experimental models of myocardial ischemia-reperfusion injury |
| Q34329506 | The role of apoptotic cell death in cardiovascular disease |
| Q37088298 | Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart |
| Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
| Q37362206 | Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death |
| Q96127259 | Uptake, efflux, and toxicity of inorganic and methyl mercury in the endothelial cells (EA.hy926) |
| Q35900913 | VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium |
| Q78019259 | [Apoptosis--what is it? Significance in coronary heart disease and myocardial infarct] |
| Q52535812 | [Cell death in inflammatory heart muscle diseases--apoptosis or necrosis?]. |
| Q34004496 | c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes. |
| Q37368100 | p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes |
| Q42122625 | p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. |
Search more.